NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events

  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download

  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download

  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download
Aura Biosciences to Participate in the JMP Securities Life Sciences Conference<
15 May 2023

Aura Biosciences to Participate in the JMP Securities Life Sciences Conference

Elisabet de los Pinos, will participate in a fireside chat at the JMP Securities Life Sciences Conference
Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights<
12 May 2023

Aura Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights

U.S. Food and Drug Administration (FDA) Guidance in Type C Meeting Supports Global Phase 3 Trial in Early-stage Choroidal Melanoma
Babyscripts and MemorialCare Mark Three-year Partnership with Significant Results in Blood Pressure Risk Identification and Patient Engagement in Maternal Populations<
11 May 2023

Babyscripts and MemorialCare Mark Three-year Partnership with Significant Results in Blood Pressure Risk Identification and Patient Engagement in Maternal Populations

Role will drive growth, focus Babyscripts’ strategic expansion in payer and provider markets
Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update<
10 May 2023

Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Awarded $15 million grant from CIRM to support the KPI-012 PCED program
Babyscripts Welcomes New Executive VP of Revenue Andrew Reeve<
03 May 2023

Babyscripts Welcomes New Executive VP of Revenue Andrew Reeve

Role will drive growth, focus Babyscripts’ strategic expansion in payer and provider markets
Mineralys Therapeutics Announces First Patient Dosed in the ADVANCE-HTN Pivotal Trial of Lorundrostat for the Treatment of Uncontrolled and Resistant Hypertension<
02 May 2023

Mineralys Therapeutics Announces First Patient Dosed in the ADVANCE-HTN Pivotal Trial of Lorundrostat for the Treatment of Uncontrolled and Resistant Hypertension

Topline data from the trial are expected in the first half of 2024 
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress<
28 Apr 2023

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress

Use of proceeds to advance Xeltis’ aXess vascular access graft into pivotal clinical trials
SparingVision Presents Progress of its Lead Gene Therapy Program SPVN06 at ARVO 2023<
27 Apr 2023

SparingVision Presents Progress of its Lead Gene Therapy Program SPVN06 at ARVO 2023

Data demonstrated the absorption and shedding of SPVN06, which was transiently observed in blood and tears, and high tropism for the retina
Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)<
25 Apr 2023

Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)

Initial evidence of disease stabilization was demonstrated for all patients using radiological, clinical and plasma biomarker assessments at 6 months (24 weeks) of treatment
Anaconda Biomed Names New Chairperson, Appoints Chief Medical Officer<
20 Apr 2023

Anaconda Biomed Names New Chairperson, Appoints Chief Medical Officer

Company Appoints De Novo Ventures Co-Founder Richard Ferrari as Chairperson, and Names Hendrik Lambert, PhD., as Chief Medical Officer

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка